The study investigates whether patients with mild SARS-CoV-2 infection, who stayed athome during their infection and weren't hospitalized, have any persisting sequelae inpulmonary function.Therefore, 110 patients, aged 6-60 years, were recruited by telephone 4-12 weeks afterlaboratory-confirmed positive PCR and invited for a lung function testing. Every patientwith abnormalities in pulmonary function was invited to a follow-up 3 months after thefirst appointment to assess changes in lung function values.Patients with a pre-existing lung disease and smokers within the last five years wereexcluded beforehand.Additionally to lung function testing we did a throat swab at each appointment to analysevia Multiplex PCR whether the patients had any other respiratory infection at the time ofthe pulmonary function testing.
110 patients, 90 adults and 20 children, were recruited. The lung function included LCI,
FEV1, FVC and DLCO (Hb corrected). Additionally we did a throat swab at each appointment
to analyse via Multiplex PCR whether the patients had any other respiratory infection at
the time of the test.
Diagnostic Test: lung function testing
lung function testing including LCI, FEV1, FVC, DLCO
Inclusion Criteria:
- SARS-CoV-2 Infection, non-hospitalized during infection
Exclusion Criteria:
- Smoking, existing lung disease (COPD, Asthma bronchiale)
Kinder- und Jugendklinik Universitätsmedizin Rostock
Rostock 2844588, Germany
Manfred Ballmann, Prof. Dr., Study Director
UMR Kinder- und Jugendklinik